Skip to main content

Medicines labeled for the same conditions

Alternatives to bromfenac

4 other medicines are given the same way (ophthalmic) and in the same FDA class as bromfenac or labeled mainly for the same use (pain); 3 are in its class, nonsteroidal anti-inflammatory drugs: ketorolac, diclofenac and nepafenac; the others include 1 corticosteroid (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $1.39 per mL (Ketorolac 0.5% eye solution) (what pharmacies paid in the NADAC survey; strengths differ).

Which medicines are labeled for the same conditions as bromfenac?

Pain lists all 80 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA classShared indicationGeneric labelers (ophthalmic)Pharmacy costBoxed warningShortage
Bromfenacnonsteroidal anti-inflammatory drugthis medicine9 labelers$13.25 per mL 0.07% eye drpNoNo current entry
Ketorolaccyclooxygenase inhibitor · same classPain17 labelers$1.39 per mL 0.5% eye solutionYesIn shortage
Diclofenacnonsteroidal anti-inflammatory drug · same classPain5 labelers$1.70 per mL 0.1% eye dropsYesA presentation being discontinued
Nepafenacnonsteroidal anti-inflammatory drug · same classPainnone listed$121.14 per mL 0.3% eye dropsNoNo current entry
LoteprednolcorticosteroidPain8 labelers$10.47 per mL 0.5% drpNoNo current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Bromfenac: the full record
label, generics, price, shortages, recalls